Document
IPR2017-01913, No. 1020-20 Exhibit - Declaration Under 37 CFR 1132 of Paul Richard Gellert in Application No 10872,784 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1020-20 Exhibit - Declaration Under 37 CFR 1132 of Paul Richard Gellert in Application No 10872,784 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1052-52 Exhibit - Howell, The Definition of the No Change Category in Patients Treated with Endocrine Therapy and Chemotherapy for Advanced Carcinoma of the Breast, 2...
Cite Document
IPR2017-01913, No. 1052-52 Exhibit - Howell, The Definition of the No Change Category in Patients Treated with Endocrine Therapy and Chemotherapy for Advanced Carcinoma of the Breast, 24 EUR J CANCER
+ More Snippets
Document
IPR2017-01913, No. 1011-11 Exhibit - Institution Decision in Mylan Pharms Inc v AstraZeneca AB, Paper No 11, IPR2016 01325 PTAB Dec 14, 2016 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1011-11 Exhibit - Institution Decision in Mylan Pharms Inc v AstraZeneca AB, Paper No 11, IPR2016 01325 PTAB Dec 14, 2016 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2172-286 Exhibit - FDA Guidance 1999 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2172-286 Exhibit - FDA Guidance 1999 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2120-234 Exhibit - Lifschitz 1999 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2120-234 Exhibit - Lifschitz 1999 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2022-136 Exhibit - Minton 1999 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2022-136 Exhibit - Minton 1999 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1084-84 Exhibit - Fabian, Clinical Pharmacology of Tamoxifen in Patients with Breast Cancer Correlation with Clinical Data, 48 CANCER 876 82 1981 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1084-84 Exhibit - Fabian, Clinical Pharmacology of Tamoxifen in Patients with Breast Cancer Correlation with Clinical Data, 48 CANCER 876 82 1981 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1066-66 Exhibit - Johnston, Changes in Estrogen Receptor, Progesterone Receptor, and pS2 Expression in Tamoxifen Resistant Human Breast Cancer, 55 CANCER RESEA...
Cite Document
IPR2017-01913, No. 1066-66 Exhibit - Johnston, Changes in Estrogen Receptor, Progesterone Receptor, and pS2 Expression in Tamoxifen Resistant Human Breast Cancer, 55 CANCER RESEARCH 3331 38 1995 (P.T.
+ More Snippets
Document
IPR2017-01913, No. 1059-59 Exhibit - Selective Estrogen Receptor Modulators SERMs, BREASTCANCERORG last modified Nov 5, 2015 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1059-59 Exhibit - Selective Estrogen Receptor Modulators SERMs, BREASTCANCERORG last modified Nov 5, 2015 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2142-256 Exhibit - Goss 1998 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2142-256 Exhibit - Goss 1998 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2037-151 Exhibit - Hortobagyi 1997 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2037-151 Exhibit - Hortobagyi 1997 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2016-130 Exhibit - Howell 1992 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2016-130 Exhibit - Howell 1992 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2154-268 Exhibit - Robertson 2016 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2154-268 Exhibit - Robertson 2016 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 2141-255 Exhibit - Dowsett Clin Cancer Res 1995 (P.T.A.B. Nov. 17, 2017)
Cite Document
IPR2017-01913, No. 2141-255 Exhibit - Dowsett Clin Cancer Res 1995 (P.T.A.B. Nov. 17, 2017)
+ More Snippets
Document
IPR2017-01913, No. 1054-54 Exhibit - Santen, Use of Aromatase Inhibitors in Breast Carcinoma, 6 ENDOCRINE RELATED CANCER 75 92 1999 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01913, No. 1054-54 Exhibit - Santen, Use of Aromatase Inhibitors in Breast Carcinoma, 6 ENDOCRINE RELATED CANCER 75 92 1999 (P.T.A.B. Aug. 4, 2017)
+ More Snippets